Erratum

Protection Against Ischemia-Induced Neuronal Damage by the α 2 -Adrenoceptor Antagonist Idazoxan: Influence of Time of Administration and Possible Mechanisms of Action Ingvar Gustafson, Eva Westerberg, Tadeusz Wieloch [ Originally published in Journal of Cerebral Blood Flow and Metabolism 1990;10(6):885–894] In last paragraph, fourth line, on page 891 of the above, the word “noradrenergic” was erroneously used in the place of “non-adrenergic.” The correct wording is as follows: “Idazoxan has affinity to non-adrenergic binding sites in the brain.” The publisher regrets this error.